drugset / Trial / NCT07215260
A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body
NaCrossoverOpen-labelTreatment
Summary
The objective of this trial is to assess the effect of BI 3000202 on the pharmacokinetics of rosuvastatin and digoxin given as a cocktail.
Timeline
- Start
- 2025-11-05
- Primary completion
- 2025-12-07
- Completion
- 2025-12-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 3000202 | Unknown | — | — |
| Subject | Digoxin | Other / unclassified | — | — |
| Subject | Rosuvastatin | Small molecule | — | — |
Indications
No indication recorded.